FDA Adverse Event Injury Summary report: N

MOLTENO3

MDR report key: 19915633 · Received August 6, 2024

Report

Report Number
3001227772-2024-00001
Event Type
Injury
Date Received
August 6, 2024
Date of Event
April 16, 2023
Report Date
August 6, 2024
Manufacturer
MOLTENO OPHTHALMIC LTD.
Product Code
KYF
UDI-DI
09419196000212
PMA / PMN Number
K062252
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADVERSE EVENT WITHOUT IDENTIFIED DEVICE OR USE PROBLEM. KNOWN INHERENT RISK OF DEVICE. FDA REPORT DELAYED DUE TO INITIAL INCORRECT ASSESSMENT OF THIS EVENT AS NOT REPORTABLE. (B)(4) . (IMPORTER) AND MOLTENO OPHTHALMIC LTD, (MANUFACTURER) ARE SUBSIDIARIES OF NOVA EYE MEDICAL LTD.

Description of Event or Problem · 0

ON 29 AUG 2023, MOLTENO OPHTHALMIC LTD BECAME AWARE OF A REPORTED ADVERSE EVENT FOR THE MOLTENO3 GLAUCOMA DRAINAGE DEVICE, (B)(6). DATE OF IMPLANT WAS (B)(6) 2023. PATIENT DETAILS OBTAINED INDICATE A POST SUPRACHOROIDAL HEMORRHAGE OCCURRED ON (B)(6) 2023 IN THE PATIENT'S RIGHT EYE DUE TO THE OPENING OF THE GLAUCOMA TUBE AND LIGATION SUTURE. CONSEQUENCE FOR THE PATIENT WAS LOSS OF VISION. THE OUTCOME ANTICIPATED BY THE SURGEON WAS LONG-TERM POOR VISION. THE INITIAL REPORT RECEIVED INDICATED THAT TWO PATIENTS HAD EXPERIENCED HYPOTONY AND LOSS OF VISION AS A RESULT OF A MOLTENO GDD IMPLANT. HOWEVER, DURING FOLLOW UP WITH THE SURGEON, ONLY ONE PATIENT DETAILS WERE PROVIDED. NO INDICATION OF HYPOTONY WAS INCLUDED IN THESE DETAILS. THE PATIENTS PRE-OP PRESSURE WAS 30MMHG IN RIGHT EYE. POST-OP PRESSURE RANGED FROM 38 TO 47MMHG ON MAXIMUM TOPICAL MEDICATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1561845 MOLTENO3 GLAUCOMA DRAINAGE DEVICE KYF MOLTENO OPHTHALMIC LTD. SS 364 09419196000212

Patients

Seq Age Sex Outcome Treatment
1 69 YR Male Other